14-91974722-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004239.4(TRIP11):​c.5479G>A​(p.Gly1827Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.322 in 1,608,338 control chromosomes in the GnomAD database, including 84,925 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1827C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.29 ( 6644 hom., cov: 30)
Exomes 𝑓: 0.32 ( 78281 hom. )

Consequence

TRIP11
NM_004239.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.31

Publications

54 publications found
Variant links:
Genes affected
TRIP11 (HGNC:12305): (thyroid hormone receptor interactor 11) This gene was identified based on the interaction of its protein product with thyroid hormone receptor beta. This protein is associated with the Golgi apparatus. The N-terminal region of the protein binds Golgi membranes and the C-terminal region binds the minus ends of microtubules; thus, the protein is thought to play a role in assembly and maintenance of the Golgi ribbon structure around the centrosome. Mutations in this gene cause achondrogenesis type IA.[provided by RefSeq, Mar 2010]
TRIP11 Gene-Disease associations (from GenCC):
  • achondrogenesis type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Laboratory for Molecular Medicine
  • TRIP11-related skeletal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029513836).
BP6
Variant 14-91974722-C-T is Benign according to our data. Variant chr14-91974722-C-T is described in ClinVar as Benign. ClinVar VariationId is 194954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.325 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIP11NM_004239.4 linkc.5479G>A p.Gly1827Ser missense_variant Exon 19 of 21 ENST00000267622.8 NP_004230.2 Q15643-1
TRIP11NM_001321851.1 linkc.5476G>A p.Gly1826Ser missense_variant Exon 19 of 21 NP_001308780.1
TRIP11XM_047431935.1 linkc.4153G>A p.Gly1385Ser missense_variant Exon 11 of 13 XP_047287891.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIP11ENST00000267622.8 linkc.5479G>A p.Gly1827Ser missense_variant Exon 19 of 21 1 NM_004239.4 ENSP00000267622.4 Q15643-1
TRIP11ENST00000554357.5 linkc.4624G>A p.Gly1542Ser missense_variant Exon 13 of 15 1 ENSP00000451032.1 H0YJ97

Frequencies

GnomAD3 genomes
AF:
0.291
AC:
44103
AN:
151466
Hom.:
6645
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.335
Gnomad SAS
AF:
0.340
Gnomad FIN
AF:
0.341
Gnomad MID
AF:
0.343
Gnomad NFE
AF:
0.327
Gnomad OTH
AF:
0.289
GnomAD2 exomes
AF:
0.306
AC:
76643
AN:
250288
AF XY:
0.316
show subpopulations
Gnomad AFR exome
AF:
0.223
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.394
Gnomad EAS exome
AF:
0.330
Gnomad FIN exome
AF:
0.330
Gnomad NFE exome
AF:
0.329
Gnomad OTH exome
AF:
0.312
GnomAD4 exome
AF:
0.325
AC:
473068
AN:
1456758
Hom.:
78281
Cov.:
33
AF XY:
0.326
AC XY:
236642
AN XY:
724834
show subpopulations
African (AFR)
AF:
0.225
AC:
7514
AN:
33414
American (AMR)
AF:
0.188
AC:
8392
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
10288
AN:
26082
East Asian (EAS)
AF:
0.375
AC:
14855
AN:
39600
South Asian (SAS)
AF:
0.345
AC:
29725
AN:
86080
European-Finnish (FIN)
AF:
0.325
AC:
17321
AN:
53326
Middle Eastern (MID)
AF:
0.323
AC:
1757
AN:
5436
European-Non Finnish (NFE)
AF:
0.328
AC:
363869
AN:
1107958
Other (OTH)
AF:
0.321
AC:
19347
AN:
60182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
15511
31022
46534
62045
77556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11768
23536
35304
47072
58840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.291
AC:
44111
AN:
151580
Hom.:
6644
Cov.:
30
AF XY:
0.291
AC XY:
21522
AN XY:
74052
show subpopulations
African (AFR)
AF:
0.227
AC:
9374
AN:
41310
American (AMR)
AF:
0.214
AC:
3256
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1349
AN:
3468
East Asian (EAS)
AF:
0.336
AC:
1733
AN:
5154
South Asian (SAS)
AF:
0.339
AC:
1626
AN:
4796
European-Finnish (FIN)
AF:
0.341
AC:
3556
AN:
10420
Middle Eastern (MID)
AF:
0.345
AC:
100
AN:
290
European-Non Finnish (NFE)
AF:
0.327
AC:
22226
AN:
67896
Other (OTH)
AF:
0.286
AC:
605
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1565
3130
4695
6260
7825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.312
Hom.:
28961
Bravo
AF:
0.278
TwinsUK
AF:
0.330
AC:
1223
ALSPAC
AF:
0.334
AC:
1287
ESP6500AA
AF:
0.223
AC:
983
ESP6500EA
AF:
0.329
AC:
2832
ExAC
AF:
0.309
AC:
37520
Asia WGS
AF:
0.305
AC:
1059
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Achondrogenesis, type IA Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Nov 17, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Odontochondrodysplasia 1 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.3
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.11
Sift
Benign
0.045
D
Sift4G
Benign
0.092
T
Polyphen
0.90
P
Vest4
0.062
MPC
0.16
ClinPred
0.027
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.22
gMVP
0.19
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1051340; hg19: chr14-92441066; COSMIC: COSV50922066; COSMIC: COSV50922066; API